PTPRU and cancer: Research by Zhou et al. indicated that miR-574-5p was involved in the progression and metastasis of NSCLC, as it enhanced the migration and invasion of cancer cells mainly through inhibiting the expression of its downstream target, protein tyrosine phosphatase receptor type U (PTPRU) [19].